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EDITORIAL
Franco-Mexican  strategic  partnership  for liver
transplantation,
Colaboración  estratégica  franco-mexicana  para  el  trasplante  hepáticoS
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tMexico  and  France  have  begun  an  effective  cooperation  in
the  ﬁeld  of  liver  transplantation.
The  cooperation  between  Mexico  and  France  in  the
health  ﬁeld  is  long-standing,  and  is  based  on  the  large  num-
ber  of  doctors  who  have  studied  in  France.
In  the  surgical  ﬁeld,  Professor  Mialleret  signed  the  ﬁrst
letter  of  intent  in  Mexico  City  more  than  50  years  ago.  This
was  ratiﬁed  in  the  name  of  the  French  National  Academy
of  Surgery  in  2003  by  its  Chairman  at  that  time,  Profes-
sor  Christian  Chatelain.  An  inter-governmental  agreement
was  signed  in  2009,  but  the  expected  development  did  not
follow.
The  beginning  of  a  new  administration  in  Mexico  in  2012,
led  to  this  cooperation  in  the  health  ﬁeld  to  be  relaunched.
This  was  realised  by  a  series  of  institutional  meetings  at
the  highest  level.  This  relaunching  re-motivated  the  French
institutions,  where  the  interest  in  Mexico  appeared  to  have
decreased.  Successively,  Inserm,  the  Pasteur  Institute,  and
the  Assistance  Publique  des  Hôpitaux  de  Paris  (Paris  Hospi-
tals  Public  Healthcare),  signed  cooperation  agreements.
The  French  and  Mexican  Academies  of  Medicine  and
Surgery,  with  the  support  of  their  respective  Chairmen,  Doc-
tor  Alejandro  Reyes  Fuentes  of  the  Academia  Mexicana  de
Cirugía  and  Doctor  Enrique  Ruelas  Barajas  of  the  Academia
Nacional  de  Medicina  de  México,  Professor  André  Laurent
Parodi  Académie  Nationale  de  Médecine  (France)  and  Profes-
sor  Jacques  Baulieux  of  the  Académie  Nationale  de  Chirurgie
(France),  in  the  presence  of  Ms.  Mercedes  Juan  López,
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under the CC BY-NC-ND license (http://creativecommons.org/licenses/becretaría  de  Salud,  México,  and  the  French  Ambassador
or  Mexico,  signed  a  cooperation  intention  agreement  to
acilitate  the  exchanges  at  the  beginning  of  2013.
In  April  2014  the  President  of  the  French  Republic,  Mr.
ranc¸ois  Hollande,  the  French  Health  Minister,  Ms.  Marisol
ouraine,  and  Mr.  Martin  Hirsch,  General  Manager  of  the
ssistance  Publique  des  Hôpitaux  de  Paris  (APHP),  were  in
exico  to  formalise  the  cooperation  agreements  in  multi-
le  ﬁelds,  including  health,  and  more  particularly  as  regards
besity  and  metabolic  diseases,  chronic  diseases  (diabetes),
ncology,  and  organ  transplantation.
In  fact,  a  letter  of  intent  protocol  as  regards  exchanges
ssociated  with  liver  transplant  was  signed  on  6  Febru-
ry  2014  between  the  Academia  Mexicana  de  Cirugía,  the
ational  Academy  of  Surgery  (France),  and  the  Instituto
exicano  del  Seguro  Social  (IMSS),  represented  by  its  Direc-
or,  Mr.  José  Antonio  González  Anaya,  in  the  presence  of  Ms.
ercedes  Juan  López,  Secretaría  de  Salud,  México.
There  is  no  doubt  that  it  is  a  clearly  demonstrated
olitical  commitment  by  the  Mexican  Government  and  the
uthorities  of  the  Instituto  Mexicano  del  Seguro  Social
IMSS),  with  the  aim  of  improving  health  care  in  this  spe-
iality  in  Mexico.  In  effect,  around  40--50  liver  transplants
re  performed  each  year,  in  the  different  IMSS  hospitals  that
rovide  a  service  for  70  million  members.  This  activity  is
hared  between  different  hospitals  of  the  IMSS.  The  project
onsists  in  regrouping  liver  transplant  into  four  hospital  cen-
res  of  the  IMSS:  two  in  the  Mexico  City,  one  in  Guadalajara,
nd  another  in  Monterrey.
The  Mexican  authorities,  who  wanted  a  rapprochement
ith  Europe,  gave  preference  to  France  to  fulﬁl  this  project,
ven  though  other  possibilities  could  be  considered.
France  is  a  pioneer  country  as  regards  transplants.  In
his  ﬁeld,  the  city  of  Lyon  has  always  been  in  the  van-
uard  of  innovation.  We  remember  the  names  of  Claude
ernard,  celebrated  doctor  and  physiologist  of  the  19th  cen-
ury,  who  discovered  the  glycogenic  function  of  the  liver
sing  his  ‘‘liver  lavage’’  experiments;  Alexis  Carrel,  a  native
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f  Lyon,  who  received  the  Nobel  Prize  in  1912.  His  vascular
nastomosis  techniques  by  ‘‘triangulation’’  made  the  ﬁrst
aw  transplants  in  dogs  possible;  Mathieu  Jaboulay,  who  in
906  performed  two  renal  xenotransplants  in  the  forearm
f  patients  with  renal  failure.  More  recently,  Jean-Michel
ubernard  performed  the  ﬁrst  pancreas  transplant  in  the
orld.  It  was  he  who  also  started  the  ﬁrst  mixed  limb  trans-
lants  in  humans,  and  later  of  the  face.
The  ﬁrst  liver  transplant  in  Lyon  was  performed  in  1976
n  the  Croix-Rousse  Hospital.  The  two  adult  liver  transplant
entres  were  located  in  only  one  place  in  2009,  in  the  Croix-
ousse  Hospital.  Approximately  2500  liver  transplants  have
een  performed  in  Lyon:  around  80  per  year  in  adults  in  the
roix-Rousse  Hospital,  and  around  10  paediatric  transplants
nnually  in  the  Femme-Mère-Enfant  Hospital  (HFME).
The  European  Liver  Transplant  Register  (ELTR)  shows  that
iver  transplants  are  currently  performed  in  155  institutions,
n  28  countries  in  Europe,  with  around  118,500  liver  being
erformed  from  1968  until  December  2013.  France  is  at  the
ead  of  the  European  countries  as  regards  this  type  of  trans-
lant,  with  21,279  transplants  being  performed  up  to  the
nd  of  December  2013.
However,  it  is  noted  that  the  annual  rate  of  liver  trans-
lants  in  France  has  currently  levelled  off  somewhat  due
o  the  limited  amount  of  cadaver  donors,  which  are  the
ain  source  of  organs  in  our  country.  These  provide  2100
ransplants  per  year,  with  a  reduced  number  of  transplants
rom  live  donors  (10--12  per  year).  A  signiﬁcant  increase
as  also  been  observed  in  the  number  of  recipients  over
5  years  of  age.  The  two  main  indications  are  liver  carci-
omas  (25%)  and  alcoholic  cirrhosis  (25%).  The  survival  at
ne  year  is  85%  (except  for  fulminating  hepatitis),  72.5%  at
ve  years,  and  62.4%  at  10  years.  The  number  of  patients
n  the  waiting  list  is  around  100  per  year  and  appears  to
e  declining.  The  average  waiting  time  for  a  transplant  is
.6  months.  Since  2007,  the  allocation  of  organs  has  been
arried  out  using  the  MELD  (Model  for  End  Stage  Liver  Dis-
ase)  score.  Although  liver  transplants  are  performed  mainly
rom  cadaver  donors,  there  is  a  special  list  for  ‘‘super  emer-
encies’’.  Priority  is  given  to  children,  for  whom  ‘‘good
onors’’  are  reserved,  and  which  usually  enables  a  split-
iver  transplantation  using  the  left  lobe  to  be  performed  on
 child.  The  right  liver  lobe  is  assigned  to  an  adult.  Resort-
ng  to  ‘‘expert  opinion’’  may  be  necessary  in  around  25%  of
ases,  which  leads  to  an  improvement  in  the  MELD  score.
n  France,  the  Biomedicine  Agency  (ABM)  is  responsible  for
he  allocations  of  organs  throughout  the  country,  in  accor-
ance  with  strict  rules  based  on  transparency,  equality,  and
ustice,  and  need  for  a  transplant.  It  is  rigorously  moni-
ored.  Activity  associated  with  transplant  is  reserved  for
ublic  hospitals.  There  are  no  payments  for  organ  donation.
rgan  trafﬁcking  is  prohibited,  as  well  as  medical  tourism  for
ransplants.
The  donation  (removal)  rate  is  approximately  25  per  mil-
ion  inhabitants,  a  little  less  than  in  Spain  where  there  is  a
edical  coordinator  in  each  large  hospital.
Recent  administrative  rules  have  stated  that  everyone
s  a  ‘‘potential  donor’’  in  that  they  have  not  indicated,
hile  alive,  to  reject  donating  organs.  The  French  Medi-
al  Ambulance  Service,  Emergency  Medical  Aid  Service,  with
ts  system,  is  very  useful  for  recruiting  donors  due  to  acci-
ents,  or  suicide,  in  a  state  of  ‘‘brain  death’’,  and  become
t
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rgan  donors.  It  is  clear  that  this  system  is  a model  that
hould  be  adopted  in  Mexico,  as  it  is  essential  to  improve
he  use  of  cadaver  donors.  A  system  of  this  type  must  be
mplemented  in  advance,  if  it  is  truly  desired  to  initiate  an
fﬁcient  transplant  program.
Media  campaigns  for  organ  donations  are  also  very  com-
on  in  France.
Either  way,  despite  everything,  there  is  no  doubt  that  we
ace  a lack  of  organs,  which  leads  to  the  increasing  use  of
‘marginal  donors’’  (steatotic  livers,  livers  from  donors
f  advanced  age,  etc.).
In  the  near  future,  the  use  of  donors  in  a  ‘‘non-beating
eart  state’’  (particularly  those  of  type  III  Maastricht)  could
e  allowed,  as  in  Great  Britain,  where  its  practice  is  nor-
al,  to  effectively  increase  the  possibilities  of  using  cadaver
onors.
The  use  of  transplants  from  ‘‘live  donors’’  has  become
ess  frequent  in  France  for  some  years,  since  the  rule  of
riority  of  ‘‘good  donors’’  for  children  was  adopted.
Thus,  it  was  in  this  favourable  context  that  the  strate-
ic  cooperation  agreement  between  France  and  Mexico
as  drawn  up  to  develop  liver  transplant  in  Mexican
erritory.
During  the  several  trips  to  Mexico,  we  can  now  prepare,
ith  the  support  of  the  International  Relations  services  of
he  Hospitales  Civiles  de  Lyon  and  the  Claude  Bernard  Lyon
 University,  a  model  cooperation  agreement  with  Insti-
uto  Mexicano  del  Seguro  Social  (IMSS).  This  agreement  is
omplete  with  an  implementation  agreement  for  liver  trans-
lant.  Managers  of  the  IMSS  have  travelled  to  Lyon  on  two
ccasions.  In  April  2014,  Mr.  José  Antonio  González  Anaya,
anaging  Director  of  the  IMSS,  and  Doctor  Javier  Dávila
orres  signed  the  basis  of  the  aforementioned  agreement
n  Lyon.  Later,  in  April  2015,  Doctor  Yamamoto,  Transplant
oordinator  of  the  IMSS,  was  in  Lyon  to  ﬁnalise  the  ﬁne
etails  of  the  exchange.  Fifty-ﬁve  physicians  of  all  speciali-
ies  that  had  anything  to  do  with  transplants  were  selected
o  attend  courses  of  6--12  months  duration.  In  ﬁnancial
erms,  the  IMSS  and  the  Mexican  Consejo  Nacional  de  Ciencia
 Tecnología  (CONACYT),  will  pay  all  the  costs.  In  accor-
ance  with  the  implementation  agreement,  the  doctors  who
ttend  the  courses  are  admitted  as  visiting  fellowships  after
hey  have  registered  in  the  Approval  of  University  Studies
f  the  Claude  Bernard  Lyon  1  University.  The  specialities  of
he  Mexican  doctors  selected  include,  anaesthesia,  resusci-
ation,  paediatric  surgery,  adult  surgery,  critical  medicine,
epatology,  histopathology,  and  radiology.  The  course  will
rovide  placements,  either  in  the  Croix-Rousse  Hospital  for
dult  transplants,  or  in  the  HFME  for  paediatric  transplants.
 training  program  was  established  by  each  person  responsi-
le  for  the  course,  which  was  validated  by  the  IMSS.  The  ﬁrst
ve  Mexican  doctors  were  received  in  Lyon  at  the  beginning
f  July  2015.
It was  within  the  framework  of  the  recent  visit  to  France
y  the  President  of  the  Mexican  Republic,  Mr.  Enrique  Pen˜a
ieto,  when  he  arrived  to  formalise  the  deﬁnitive  signing
f  this  strategic  cooperation  on  13  July  2015.  The  signing
y  Mr.  José  Antonio  González  Anaya,  Managing  Director  of
he  IMSS,  and  by  Professor  Denis  Bourgeois,  Vice-Chairman
nd  representative  of  International  Relations  and  European
elations  of  the  Claude  Bernard  Lyon  1  University,  took  place
n  Paris,  in  the  presence  of  the  President  of  the  Mexican
c
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Republic.  President  Pen˜a  Nieto  was  interviewed  on  that  day
along  with  doctors  of  the  French-Mexican  Strategic  Cooper-
ation  for  Liver  Transplant.
In  about  eighteen  months  there  could  be  selected  Mex-
ican  doctors  who  could  work  in  a  team  in  the  four  hospital
services  envisaged  by  the  IMSS.  At  the  same  time,  the  nec-
essary  operational  strategy  will  have  to  be  implemented
for  the  extraction  of  cadaver  donor  organs,  which  will
be  an  essential  condition  for  the  success  of  this  project.
This  should  enable  the  obtaining  of  the  required  ‘‘volume
effect’’  so  that  liver  transplantation  can  again  become  an
activity  carried  out  ‘‘routinely’’  in  Mexico,  being  fully  com-
petitive  with  the  rest  of  the  countries  of  North  America  and
Latin  America.363
This  ﬁne  example  of  the  rapprochement  of  our  two
ountries,  separated  by  the  oceans,  for  such  an  ambitious
roject  should  serve  as  a model  for  other  ﬁelds  in  the  Franco-
exican  Medical  Cooperation.  The  processes  of  this  program
nitiated  by  the  different  Medical  and  Surgical  Academies  of
exico  and  France  have  become  a  reality.
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